Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K172864
    Date Cleared
    2018-05-02

    (224 days)

    Product Code
    Regulation Number
    880.6250
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    A powder free nitrile examination glove is a disposable device intended for medical purposes that is worn on the examiner's hands and finger to prevent contamination between patient and examiner. In addition, these gloves were tested for use with chemotherapy drugs in accordance with ASTMD6978-05 Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs:

    Device Description

    These patient examination gloves are formulated using nitrile, non-sterile, powder free, meet all the requirements of ASTM D6319 and tested for use with chemotherapy drugs.

    AI/ML Overview

    The provided text describes the acceptance criteria and performance of "Non-Sterile Powder Free Blue Nitrile Examination Gloves Tested for Use with Chemotherapy Drugs." This is a medical device, and the data presented relates to its physical and chemical properties, not an AI/ML powered device. Therefore, many of the requested fields are not applicable.

    Here's the information extracted from the document based on the prompt:

    1. A table of acceptance criteria and the reported device performance

    CharacteristicsStandardsAcceptance Criteria (Predicate)Reported Device Performance (Current)
    Manufacturer-Kossan International Sdn BhdMaxter Gloves Manufacturing Sdn Bhd
    510 (K) Number-K151750K172864
    DimensionsASTM D6319-10≥ 230mm≥ 230mm
    Physical PropertiesASTM D6319-10MeetMeet
    Thickness - Finger - PalmASTM D6319-10≥ 0.05mm≥ 0.05mm
    Freedom From HolesASTM D6319-10 and ASTM D5151PassPass
    Powder Free ResidueASTM D6319-10 and ASTM D6124MeetMeet
    Resistance to Permeation by Chemotherapy Drugs (ASTM D6978-05)
    Carmustine (BCNU) 3.3mg/mlConcentration10.1 minutes8.3 minutes
    Cisplatin 1.0mg/mlConcentration>240 minutes>240 minutes
    Cyclophosphamide (Cytoxan) 20mg/mlConcentration>240 minutes>240 minutes
    Cytarabine 100mg/mlConcentration>240 minutes>240 minutes
    Dacarbazine (DTIC) 10.0mg/mlConcentration>240 minutes>240 minutes
    Doxorubicin Hydrochloride 2.0mg/mlConcentration>240 minutes>240 minutes
    Etoposide (Toposar) 20.0mg/mlConcentration>240 minutes>240 minutes
    Fluorouracil 50.0 mg/mlConcentrationNot explicitly stated for Predicate in table, but indicated as >240 for Current device. Given the "similar to predicate" statement, it's reasonable to infer a similar acceptance criteria.>240 minutes
    Ifosfamide 50.0 mg/mlConcentration>240 minutes>240 minutes
    Methotrexate 25mg/mlConcentration>240 minutes>240 minutes
    Mitomycin C 0.5mg/mlConcentration>240 minutes>240 minutes
    Mitoxantrone 2.0mg/mlConcentration>240 minutes>240 minutes
    Paclitaxel (Taxol) 6.0mg/mlConcentration>240 minutes>240 minutes
    Thiotepa 10.0mg/mlConcentration30.2 minutes38.0 minutes
    Vincristine Sulfate 1.0mg/mlConcentration>240 minutes>240 minutes
    Warning Statement-Warning: Please note that the following drugs have extremely low permeation times: Carmustine(BCNU): 10.1 minutes and Thiotepa: 30.2 minutesWarning: Please note that the following drugs have low permeation time of less than 240 minutes: Carmustine (BCNU): 8.3 minutes and Thiotepa: 38.0 minutes. Do not use with Carmustine or Thiotepa.
    Biocompatibility: Primary Skin IrritationISO 10993Non-irritantNon-irritant
    Biocompatibility: Dermal SensitizationISO 10993Non-sensitizerNon-sensitizer
    Biocompatibility: In vitro CytotoxicityISO 10993Not available (for Predicate)The device extract was not cytotoxic.
    MaterialASTM D6319-10NitrileNitrile
    Color-Blue, and whiteBlue
    Texture-Finger TexturedFinger Textured
    SizeMedical Glove Guidance Manual-LabelingExtra Small, Small, Medium, Large, Extra LargeExtra Small, Small, Medium, Large, Extra Large
    Single UseMedical Glove Guidance Manual-LabelingSingle useSingle use

    2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

    The document does not explicitly state the sample size for the tests conducted to determine the breakthrough detection times or other physical properties. It generally refers to conducting tests "in accordance with ASTMD6978-05 Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs," and other ASTM and ISO standards. These standards typically specify sample sizes for their respective tests. The provenance of the data is implied to be from the manufacturer's testing (Maxter Glove Manufacturing Sdn Bhd) in Malaysia, as they are the submitter of the 510(k). The tests are prospective in nature, as they are performed to demonstrate compliance with standards for the device being submitted.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

    Not applicable. This is a physical device (gloves) and the "ground truth" is established through standardized laboratory testing against chemical permeation and physical properties, not through expert consensus on medical images or diagnoses.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    Not applicable. This is a physical device.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    Not applicable. This is a physical device, not an AI/ML powered medical device.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    Not applicable. This is a physical device.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

    The "ground truth" for this device is based on objective measurements conducted according to established international and national standards (e.g., ASTM D6319-10, ASTM D5151, ASTM D6124, ASTM D6978-05, ISO 10993). This involves laboratory measurements for physical dimensions, tensile strength, elongation, freedom from holes, powder residue levels, breakthrough time for chemotherapy drugs, and biocompatibility endpoints (irritation, sensitization, cytotoxicity).

    8. The sample size for the training set

    Not applicable. This is a physical device, not an AI/ML-powered device that requires a training set.

    9. How the ground truth for the training set was established

    Not applicable. This is a physical device.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1